This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover work from home jobs that pay weekly and boost your income. Start earning from the comfort of your home today!
14,667 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
With $1,000, you can build a resilient, diversified starter portfolio. This guide shows how to pick the best stocks w...
In a choppy market, SPHD delivers income built bear markets through a defensive mix of high-dividend, low-volatility ...
Retirement success isn’t about chasing one hot stock. It’s about a well-balanced mix of growth, income, and safety. L...
Lithium Americas has gained 32% in the last year as Thacker Pass advances, but rising share dilution and mounting cap...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Palantir is venturing into a new market via Polymarket, sparking questions about its AI growth path. This guide lays ...
Cambridge Mobile Telematics has raised $350 million in a strategic round led by TPG Rise Funds and Allianz X, with St...
As mortgage markets tighten and churn rises, lenders are turning to mentorship to convert recruits into steady, produ...
Billionaire Bill Ackman recently shifted gears, selling a former cornerstone stake to fund two AI stock bets. This mo...
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
Could Ethereum steal the spotlight from Bitcoin in the next three years? This guide lays out the case, the risks, and...